Heart failure affects more than 64 million people worldwide and remains a leading driver of cardiovascular morbidity and mortality. Adverse cardiac ...

Elevated levels of lipoprotein(a) seem to be associated with greater subclinical interstitial myocardial fibrosis (IMF), increased myocardial scar prevalence, and left atrial remodeling by cardiac ...

Increased risk for adverse cardiovascular outcomes, including myocardial fibrosis, is associated with elevated lipoprotein(a) levels. Elevated lipoprotein(a) (Lp[a]) levels are associated with ...

Chronic exposure to fine particulate matter with an aerodynamic diameter ≤ 2.5 and ≤ 10 µm (PM 2.5 and PM 10, respectively) was associated with elevated cardiac magnetic resonance (CMR) markers of ...

A study in Frontiers of Medicine explores the role of the m 6 A reader YTHDF1 in cardiac fibrosis, a condition characterized by the excessive accumulation of extracellular matrix proteins, leading to ...

Older male endurance athletes may be at a higher risk for cardiac arrhythmias while exercising if they have scarring in their hearts, according to a study published in the European Journal of ...

Cardiac fibrosis impacts millions of patients and currently has no effective therapy. Stanford Cardiovascular Institute researchers have uncovered a new mechanosensing-based mechanism that reduces ...

Through a comprehensive approach combining transcriptomic profiling, histological analysis, and functional validation in organoid and animal models, a research team led by Associate Professor ...